Long-read genome sequencing is emerging as a primary diagnostic tool for rare genetic disorders, potentially replacing up to fifteen standard tests. According to researchers at Radboud University Medical Center and Maastricht UMC+, this technology provides a more complete DNA map by reading segments of 20,000 building blocks compared to the 300-block fragments used in current diagnostics. The findings, published in the New England Journal of Medicine, suggest this method increases diagnostic yield by three percent.
How Long-Read Sequencing Improves Diagnosis
Current diagnostic standards rely on short-read sequencing, which functions like a jigsaw puzzle with tiny, difficult pieces. By contrast, long-read sequencing processes significantly larger DNA segments. Professor of Translational Genomics Lisenka Vissers notes that this approach simplifies the assembly of the genetic sequence, leading to a more accurate and comprehensive picture of a patient’s genome. Because the test captures both the genetic code and external modifications—which can switch genes on or off—it functions as a “two-in-one” diagnostic tool, according to Christian Gilissen, Professor of Genome Bioinformatics at Radboudumc.
A condition is classified as “rare” if it affects fewer than one in 2,000 people. Despite this classification, approximately 400 million people worldwide live with a rare disease, 80 percent of which have a genetic origin.
The Shift from Multiple Tests to Single-Platform Diagnostics
Medical centers currently rely on a series of fragmented tests to identify rare genetic abnormalities, a process that can take years. The new protocol aims to streamline this by consolidating multiple diagnostic steps into a single long-read analysis. Researchers involved in the study recommend this test as the first-choice diagnostic for rare disorders. By mapping the DNA in detail, the technology identifies complex abnormalities that are often invisible to standard short-read methods. During a recent “Undiagnosed Hackathon” in Nijmegen, this technique helped specialists secure five new diagnoses for 33 families.
Future Impacts on Genetic Medicine
The ability to detect previously “hidden” genetic variations is expected to increase the total number of diagnosed cases over time. Professor of Genomic Technologies Alexander Hoischen states that as researchers continue to link these newly identified complex abnormalities to specific clinical conditions, the global knowledge base for rare diseases will expand. This diagnostic clarity offers families essential insights into future health risks, potential treatment paths, and reproductive planning.
Frequently Asked Questions
- Why is long-read sequencing better than current tests? It reads DNA in much longer segments, making it easier to assemble the genome and identify complex abnormalities that short-read tests often miss.
- What is the primary benefit for patients? It reduces the need for multiple, time-consuming diagnostic tests and provides a faster path to a definitive diagnosis.
- Does the test identify non-genetic causes? The test focuses on DNA and the external modifications that switch genes on or off, which are critical for diagnosing genetically-linked rare diseases.
If you or a family member are navigating the diagnostic process for a suspected rare condition, ask your genetic counselor about the availability of long-read sequencing compared to standard whole-exome or whole-genome sequencing.
Are you interested in the latest breakthroughs in genomic medicine? Subscribe to our newsletter to receive updates on how new diagnostic technologies are changing patient outcomes.
